Historical Stock Price
ETFs Holding AQXP »    Stock Splits Calendar »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
08/05/2019 $2.78 $2.97 $2.68 $2.88 75.60K
08/06/2019 $2.97 $3.18 $2.41 $2.92 1.36M
08/07/2019 $2.94 $3.30 $2.86 $3.28 792.20K
08/08/2019 $3.29 $3.69 $3.27 $3.47 418.90K
08/09/2019 $3.50 $3.84 $3.46 $3.68 513.90K
Aquinox Pharmaceuticals is a clinical-stage pharmaceutical company discovering and developing therapeutics for chronic urological conditions marked by inflammation and pain. Co.'s primary drug candidate, rosiptor, for the treatment of patients with interstitial cystitis/bladder pain syndrome (IC/BPS). Co. is focused on utilizing its library of novel compounds that activate SHIP1 (SH2-containing inositol-5'-phosphatase to develop therapeutics for application in inflammation, inflammatory pain, and blood cancers.
AQXP historical stock prices picture
AQXP (AQXP) has the following price history information. Looking back at AQXP historical stock prices for the last five trading days, on August 05, 2019, AQXP opened at $2.78, traded as high as $2.97 and as low as $2.68, and closed at $2.88. Trading volume was a total of 75.60K shares. On August 06, 2019, AQXP opened at $2.97, traded as high as $3.18 and as low as $2.41, and closed at $2.92. Trading volume was a total of 1.36M shares. On August 07, 2019, AQXP opened at $2.94, traded as high as $3.30 and as low as $2.86, and closed at $3.28. Trading volume was a total of 792.20K shares. On August 08, 2019, AQXP opened at $3.29, traded as high as $3.69 and as low as $3.27, and closed at $3.47. Trading volume was a total of 418.90K shares. On August 09, 2019, AQXP opened at $3.50, traded as high as $3.84 and as low as $3.46, and closed at $3.68. Trading volume was a total of 513.90K shares.

AQXP Historical Stock Prices By Date:

AQXP historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into AQXP shares, starting with a $10,000 purchase of AQXP, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/07/2014
End date: 08/09/2019
Start price/share: $11.95
End price/share: $3.68
Dividends collected/share: $0.00
Total return: -69.21%
Average Annual Total Return: -19.52%
Starting investment: $10,000.00
Ending investment: $3,078.86
Years: 5.42
Date Close
08/05/2019$2.88
08/06/2019$2.92
08/07/2019$3.28
08/08/2019$3.47
08/09/2019$3.68
AQXP is categorized under the Healthcare sector; below are some other companies in the same sector:

ARA Historical Stock Prices
ARAY Historical Stock Prices
ARDM Historical Stock Prices
ARDX Historical Stock Prices
ARGS Historical Stock Prices
ARIA Historical Stock Prices
ARNA Historical Stock Prices
ARQL Historical Stock Prices
ARRY Historical Stock Prices
ARTC Historical Stock Prices

Also explore: AQXP shares outstanding history

AQXP Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.